ClinicalTrials.gg
Not yet recruitingNCT07366996Updated Jan 26, 2026

Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent

An interventional study of Schroth treatment and Scientific Exercise Approach to Scoliosis (SEAS) in Idiopathic Scoliosis, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Scoliosis by Cairo University — 5 open to participants now, 5 under way, none of them phase 3. Scoliosis · Cairo University.

Started
2026
with 2 others
No phase
9 of 13
4 open now
Registered
11th of 13
by date

Among the 13 studies in Scoliosis by Cairo University, this one is one of 3 that started in 2026, is one of 9 with no phase, and was the 11th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

5 of the 13 studies in Scoliosis by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 13 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Scoliosis by Cairo University, or all of them as a file.
02

Study summary

This study aims to compare the effectiveness of "Schroth method" and "Scientific Exercise Approach to Scoliosis" for correcting idiopathic scoliosis in adolescents.

Read the detailed description

The Schroth Method has gained prominence in the treatment of scoliosis due to its individualized approach, focusing on three-dimensional corrections through specific exercises tailored to each patient's spinal curvature. This method emphasizes rotational breathing and postural awareness, aiming to improve posture, reduce pain, and halt curve progression. Studies have shown that the Schroth Method can effectively improve spinal alignment, reduce curve severity, and enhance overall quality of life in patients with scoliosis. As a non-surgical intervention, it offers a valuable option for patients seeking to manage scoliosis conservatively. In contrast, the Scientific Exercise Approach to Scoliosis (SEAS) is another evidence-based method designed to treat scoliosis. SEAS focus on active self-correction, proprioceptive training, and functional exercises to stabilize and support the spine during daily activities. This approach is grounded in the principles of biomechanics and motor control, with an emphasis on developing the patient's ability to maintain correct posture independently. SEAS has been shown to be effective in reducing the risk of scoliosis progression and in some cases, it may reduce the need for bracing or surgery.

Comparing the Schroth Method and Scientific Exercise Approach to Scoliosis reveals significant insights into their respective benefits and limitations. While both approaches aim to address scoliosis through non-invasive means, they differ in their specific techniques and theoretical foundations. The Schroth Method's emphasis on breathing and postural correction contrasts with SEAS's focus on active self-correction and functional integration. Understanding these differences is crucial for clinicians to tailor treatment plans according to individual patient needs and preferences. This comparative study aims to provide deeper insights into the efficacy of these two approaches, potentially guiding more effective treatment strategies for adolescents with idiopathic scoliosis.

03

Conditions studied

  • Idiopathic Scoliosis

Browse trials for

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Teenagers diagnosed with typical idiopathic scoliosis.
  • Teenagers aged 13 to 18 years
  • Both genders will be included.
  • Participants with a Cobb angle ranging from 10° to 25°, as determined by radiographic analysis.
  • Participants with Risser sign of 2 to 3, indicating incomplete skeletal maturity.
  • Participants must be able to understand and follow instructions, ensuring effective participation in the treatment protocol.

Exclusion criteria

Exclusion Criteria:

  • Adolescents with significant visual or auditory impairments that could interfere with the ability to participate in or benefit from the rehabilitation programs.
  • Adolescents with cognitive, mental, or psychological disorders that hinder understanding or following the instructions necessary for the treatment protocol.
  • Adolescents who have previously undergone spinal surgery or any surgical interventions related to scoliosis or other spinal conditions.
  • Adolescents with non-idiopathic scoliosis or scoliosis secondary to other underlying conditions (e.g., neuromuscular, congenital, or syndromic scoliosis).
  • Adolescents with fixed spinal deformities that are not amenable to correction through non-surgical 3D approach.
  • Adolescents with concurrent musculoskeletal conditions that could interfere with the treatment or assessment of scoliosis (e.g., significant hip or knee deformities).
  • Adolescents currently participating in other clinical trials or receiving treatments that might confound the study results.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Schroth treatment

    Fifteen adolescents will participate in one-hour Schroth treatment sessions, conducted three times per week in center under therapist supervision on non-consecutive days.

    Other: Schroth treatment

  • Experimental
    Scientific Exercise Approach to Scoliosis (SEAS)

    The home program will consist of fifteen adolescents coming to the center once a month for Scientific Exercise Approach to Scoliosis (SEAS) treatment sessions, each lasting one hour. These sessions will be conducted three days per week, one hour, at home on non-consecutive days.

    Other: Scientific Exercise Approach to Scoliosis (SEAS)

Interventions

  • OtherSchroth treatment

    The exercise program targets three-dimensional spinal correction and includes Schroth breathing for rib cage expansion, pelvic tilts for pelvic alignment, side-shift exercises for lateral correction, rotational angular breathing for derotation, seated rotational stretches for lumbar flexibility, trunk elongation with resistance for postural strength, hanging stretches for spinal decompression, and arm-leg lifts to enhance core stability and coordination.

  • OtherScientific Exercise Approach to Scoliosis (SEAS)

    The SEAS exercise program emphasizes active self-correction, core stability, and postural control during functional movements. Key exercises include pelvic tilts, seated forward bends, standing side bends, supine marching, bird-dog, heel slides, chest openers, and supine knee-to-chest stretches, all performed with self-correction to maintain neutral spinal alignment, improve muscular control, flexibility, and long-term postural stability.

06

What researchers measure

Primary outcomes

  1. Cobb Angle

    It will be assessed using standard standing posteroanterior spinal radiographs and will be measured before and after the intervention period. This outcome measure will be used to quantify the magnitude of the lateral spinal curvature and to evaluate changes in spinal alignment, allowing determination of the degree of curve correction or progression following the intervention.

    Time frame: 12 weeks

  2. Angle of Trunk Rotation (ATR)

    It will be measured using a scoliometer during the Adam's forward bend test and will be assessed before and after the intervention period. This outcome measure will be used to evaluate the degree of rotational trunk deformity, reflecting the axial component of the three-dimensional spinal deformity in scoliosis.

    Time frame: 12 weeks

Secondary outcomes

  1. Risser Sign

    It will be evaluated using pelvic radiographs and will serve as an indicator of skeletal maturity. This outcome measure will be used to estimate remaining growth potential and to assess the risk of scoliosis curve progression during the growth period.

    Time frame: 12 weeks

  2. Health-Related Quality of Life (HRQOL)

    It will be assessed using validated Arabic versions of the Scoliosis Research Society-22 (SRS-22) questionnaire or the Pediatric Quality of Life Inventory (PedsQL). These instruments will be used to evaluate multiple domains affected by scoliosis, including pain, functional status, self-image, emotional well-being, and social functioning, providing a comprehensive measure of patients' perceived health and overall quality of life.

    Time frame: 12 weeks

07

Study locations

1 site
  • Faculty of Physical Therapy - Delta University for Science and Technology
    Gamasa, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for May 2026, 3 months later.

Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 3 months is below that.

Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2026
First posted
Jan 26, 2026
StartEst.
Feb 1, 2026
Primary completionEst.
May 1, 2026
CompletionEst.
May 15, 2026
Last update
Jan 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07366996
Lead sponsor
Cairo University
Responsible party
Mina Reda Rezk Nada (Principal Investigator, Cairo University) — Principal investigator
First posted
Jan 26, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
May 1, 2026 (estimated)
Completion
May 15, 2026 (estimated)
Last update
Jan 26, 2026

Study contacts

Mina Reda Rezk Nada, M.Sc
Contact
Mina.physicaltherapy@gmail.com
+20 12 80270902
Maya Galal Abd El Wahab, PhD
Contact
Khaled Olama, PhD
study chair · Professor, Cairo University
Maya Galal Abd El Wahab, PhD
study director · Ass. Professor, Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion